GERPINNES PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GERPINNES PHARMA
Largest movements
- Tangible fixed assets -€142,580
down €142,580 (-10.5%), from €1.4m to €1.2m
of which Land and buildings: -€124,194
- Stocks and contracts +€59,770
up €59,770 (+25.8%), from €231,240 to €291,010
- Receivables within one year +€57,743
up €57,743 (+30.6%), from €188,452 to €246,195
of which Trade receivables: +€42,882
- Intangible fixed assets -€43,003
down €43,003 (-66.7%), from €64,504 to €21,501
- Trade debts -€796,951
down €796,951 (-48.6%), from €1.6m to €844,499
- Other debts +€689,850
up €689,850 (+1146.9%), from €60,150 to €750,000
- Tax, wage and social debts +€29,030
up €29,030 (+170.2%), from €17,052 to €46,082
- Gross operating margin +€133,764
up €133,764 (+48.7%), from €274,616 to €408,380
- Staff costs +€66,684
up €66,684 (+40.4%), from €165,083 to €231,767
- Financial income -€15,098
down €15,098 (-25.9%), from €58,192 to €43,094
- Financial charges -€5,242
down €5,242 (-35.8%), from €14,644 to €9,402
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,146,677 | €2,080,960 | -€65,717 | -3.1% |
| Fixed assets | 21/28 | €1,427,218 | €1,241,635 | -€185,583 | -13.0% |
| Intangible fixed assets | 21 | €64,504 | €21,501 | -€43,003 | -66.7% |
| Tangible fixed assets | 22/27 | €1,362,714 | €1,220,134 | -€142,580 | -10.5% |
| Land and buildings | 22 | €1,260,360 | €1,136,166 | -€124,194 | -9.9% |
| Plant, machinery and equipment | 23 | €69,868 | €57,038 | -€12,830 | -18.4% |
| Furniture and vehicles | 24 | €32,486 | €26,930 | -€5,556 | -17.1% |
| Current assets | 29/58 | €719,459 | €839,325 | +€119,866 | +16.7% |
| Stocks and contracts in progress | 3 | €231,240 | €291,010 | +€59,770 | +25.8% |
| Stocks | 30/36 | €231,240 | €291,010 | +€59,770 | +25.8% |
| Amounts receivable within one year | 40/41 | €188,452 | €246,195 | +€57,743 | +30.6% |
| Trade receivables | 40 | €182,599 | €225,481 | +€42,882 | +23.5% |
| Other amounts receivable | 41 | €5,853 | €20,714 | +€14,861 | +253.9% |
| Cash at bank and in hand | 54/58 | €299,767 | €302,120 | +€2,353 | +0.8% |
| Total equity and liabilities | 10/49 | €2,146,677 | €2,080,960 | -€65,717 | -3.1% |
| Equity | 10/15 | €426,591 | €438,945 | +€12,354 | +2.9% |
| Contributions | 10/11 | €862,000 | €862,000 | = | 0.0% |
| Capital | 10 | €862,000 | €862,000 | = | 0.0% |
| Issued capital | 100 | €862,000 | €862,000 | = | 0.0% |
| Reserves | 13 | €6,200 | €6,200 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€441,609 | -€429,255 | +€12,354 | +2.8% |
| Amounts payable | 17/49 | €1,720,086 | €1,642,015 | -€78,071 | -4.5% |
| Amounts payable within one year | 42/48 | €1,720,086 | €1,642,015 | -€78,071 | -4.5% |
| Trade debts | 44 | €1,641,450 | €844,499 | -€796,951 | -48.6% |
| Suppliers | 440/4 | €1,641,450 | €844,499 | -€796,951 | -48.6% |
| Advances received on contracts in progress | 46 | €1,434 | €1,434 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €17,052 | €46,082 | +€29,030 | +170.2% |
| Remuneration and social security | 454/9 | €17,052 | €46,082 | +€29,030 | +170.2% |
| Other amounts payable | 47/48 | €60,150 | €750,000 | +€689,850 | +1146.9% |
| Remuneration, social security and pensions | 62 | €165,083 | €231,767 | +€66,684 | +40.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €193,076 | €194,152 | +€1,076 | +0.6% |
| Other operating charges | 640/8 | €3,090 | €3,799 | +€709 | +22.9% |
| Gross operating margin | 9900 | €274,616 | €408,380 | +€133,764 | +48.7% |
| Operating profit (loss) | 9901 | -€86,633 | -€21,338 | +€65,295 | +75.4% |
| Financial income | 75/76B | €58,192 | €43,094 | -€15,098 | -25.9% |
| Recurring financial income | 75 | €58,192 | €43,094 | -€15,098 | -25.9% |
| Financial charges | 65/66B | €14,644 | €9,402 | -€5,242 | -35.8% |
| Recurring financial charges | 65 | €14,644 | €9,402 | -€5,242 | -35.8% |
| Profit (loss) for the period before taxes | 9903 | -€43,085 | €12,354 | +€55,439 | |
| Profit (loss) for the period | 9904 | -€43,085 | €12,354 | +€55,439 | |
| Profit (loss) for the period to be appropriated | 9905 | -€43,085 | €12,354 | +€55,439 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.